Pharmacokinetics of ketoprofen in healthy horses and horses with acute synovitis

J Vet Pharmacol Ther. 1995 Jun;18(3):187-95. doi: 10.1111/j.1365-2885.1995.tb00577.x.

Abstract

The pharmacokinetic properties of a single intravenous dose of ketoprofen (2.2 mg/kg) in plasma and synovial fluid were compared in four healthy animals and four horses with experimentally induced acute synovitis. Synovitis was induced by the injection of a 1% solution of sterile carrageenan into the left intercarpal joint. Ketoprofen was administered at the same time as carrageenan infection. The plasma disposition followed a biexponential equation or a two-compartment model in most horses. The plasma harmonic mean half-life in healthy horses (0.88 h) was longer than in horses with synovitis (0.55 h). Synovial fluid concentrations of ketoprofen in healthy horses approximated those in plasma by 3 h post-dose. In horses with synovitis, synovial fluid concentrations approximated plasma concentrations by 1 h. Synovial fluid concentrations of ketoprofen in horses with synovitis were 6.5 times higher than those in healthy horses at 1 h. The area under the synovial fluid concentration curve for horses with synovitis was greater than in healthy horses. These data suggest that the inflamed joint serves as a site of sequestration for ketoprofen. Furthermore, these results indicate that plasma pharmacokinetics may be altered by inflammation in a peripheral compartments such as the joint.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Animals
  • Carrageenan
  • Female
  • Half-Life
  • Horse Diseases / chemically induced
  • Horse Diseases / metabolism*
  • Horses / metabolism*
  • Injections, Intravenous / veterinary
  • Ketoprofen / administration & dosage
  • Ketoprofen / blood
  • Ketoprofen / pharmacokinetics*
  • Male
  • Synovial Fluid / metabolism
  • Synovitis / chemically induced
  • Synovitis / metabolism
  • Synovitis / veterinary*

Substances

  • Carrageenan
  • Ketoprofen